SOURCE: Rotoblock

April 08, 2011 14:22 ET

Rotoblock Appoints Experienced Directors to Board

SANTA ROSA, CA--(Marketwire - Apr 8, 2011) - Rotoblock Corp. (OTCBB: RTBC), a publicly-owned California-based corporation investing in emerging technology opportunities in China, appointed Michael Choy and Andrew Chow to its Board of Directors.

Dr Michael H. Choy is founder and chairman of daifuWaste Management Holding Limited, a leader in sustainable medical waste treatment in China. As an entrepreneur, he founded Tiantan Puhua Biomedical Inc., a biotech company focusing on stem cell research and disease treatment in China, as well as daifuMD (Holding) Inc., a web referral enterprise connecting patients to medical specialties across China.

Dr. Choy is a graduate of the University of California, Berkeley and California College of Podiatric Medicine, serving his surgical residency at University of California, Los Angeles, Wadsworth Medical Center. Upon graduation Dr. Choy established a successful private practice serving the populations of three counties in Northern California. In 1992 he founded a partnership of thirty-five U.S. medical doctors called Asia Pacific Medical Group (APMG) one of the largest private hospital chains in China, where he has served as chairman and CEO.

"We are truly fortunate to have one of the pioneers in China's medical waste disposal field with the addition of Dr. Choy," said Chien Chih Liu, Chief Executive Officer of Rotoblock. "We believe this will help accelerate the rollout of our next phase of development."

Along with Dr. Choy, Rotoblock has appointed Mr. Andrew Chow to its Board of Directors. Mr. Chow is the Director and Senior Vice President of Finance for American Pacific Medical Group, a medical group owning 10 hospitals in China that was started by 35 medical doctors. Mr. Chow joined APMG in 1996. He is Fellow of the Chartered Association of Certified Accountants as well as an associate of the Chartered Institute of Management Accountants in the United Kingdom. Mr. Chow is also an Associate of Hong Kong Institute of Certified Public Accountants.

"With the addition of Dr. Choy and Andrew Chow, we are recruiting experience, in-depth knowledge of the industry as well as veteran financial and business management to our team. Having two such people from the medical industry will help form a solid foundation for the implementation of the new company," said Mr. Liu.

Contact Information


    Chien Chih Liu
    Chief Executive Officer